KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Gains from Sales and Divestitures (2017 - 2025)

Fulgent Genetics' Gains from Sales and Divestitures history spans 9 years, with the latest figure at $1.0 million for Q4 2025.

  • On a quarterly basis, Gains from Sales and Divestitures rose 4.48% to $1.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.0 million, a 4.48% increase, with the full-year FY2025 number at $1.0 million, up 4.48% from a year prior.
  • Gains from Sales and Divestitures hit $1.0 million in Q4 2025 for Fulgent Genetics, up from $1.0 million in the prior quarter.
  • Over the last five years, Gains from Sales and Divestitures for FLGT hit a ceiling of $1.1 million in Q4 2023 and a floor of $699000.0 in Q4 2022.
  • Historically, Gains from Sales and Divestitures has averaged $930800.0 across 5 years, with a median of $1.0 million in 2024.
  • Biggest five-year swings in Gains from Sales and Divestitures: dropped 16.39% in 2022 and later surged 52.5% in 2023.
  • Tracing FLGT's Gains from Sales and Divestitures over 5 years: stood at $836000.0 in 2021, then dropped by 16.39% to $699000.0 in 2022, then soared by 52.5% to $1.1 million in 2023, then fell by 5.82% to $1.0 million in 2024, then increased by 4.48% to $1.0 million in 2025.
  • Business Quant data shows Gains from Sales and Divestitures for FLGT at $1.0 million in Q4 2025, $1.0 million in Q4 2024, and $1.1 million in Q4 2023.